
November 2, 2017 - By Stephen Andrade
Northern Cross Llc decreased its stake in Ambev Sa (ABEV) by 1.91% based on its latest 2017Q2 regulatory filing with the SEC. Northern Cross Llc sold 180,387 shares as the company’s stock declined 1.05% while stock markets rallied. The institutional investor held 9.25M shares of the beverages (production and distribution) company at the end of 2017Q2, valued at $50.79M, down from 9.43M at the end of the previous reported quarter. Northern Cross Llc who had been investing in Ambev Sa for a number of months, seems to be less bullish one the $98.86 billion market cap company. The stock declined 0.56% or $0.03 reaching $6.26 per share. About 14.85M shares traded. Ambev SA (ADR) (NYSE:ABEV) has risen 10.52% since November 2, 2016 and is uptrending. It has underperformed by 6.18% the S&P500.Denali Advisors Llc increased its stake in Quest Diagnostics Inc (DGX) by 20.89% based on its latest 2017Q2 regulatory filing with the SEC. Denali Advisors Llc bought 13,700 shares as the company’s stock rose 10.72% with the market. The institutional investor held 79,271 shares of the medical specialities company at the end of 2017Q2, valued at $8.81 million, up from 65,571 at the end of the previous reported quarter. Denali Advisors Llc who had been investing in Quest Diagnostics Inc for a number of months, seems to be bullish on the $12.75B market cap company. The stock rose 0.47% or $0.44 reaching $93.54 per share. About 818,163 shares traded. Quest Diagnostics Inc (NYSE:DGX) has risen 39.04% since November 2, 2016 and is uptrending. It has outperformed by 22.34% the S&P500.More notable recent Ambev SA (ADR) (NYSE:ABEV) news were published by: Gurufocus.com which released: “Seeking Value in Brazil: Ambev” on May 28, 2017, also Livetradingnews.com with their article: “Ambev SA (ADR) (NYSE:ABEV) Short Term Downward Trend” published on October 24, 2017, Investorplace.com published: “Ambev SA (ADR) (ABEV) Stock: Invest Without the Froth” on July 12, 2017. More interesting news about Ambev SA (ADR) (NYSE:ABEV) were released by: Livetradingnews.com and their article: “Ambev SA (ADR) (NYSE:ABEV) Daily Technical Outlook” published on October 31, 2017 as well as Stockhouse.com‘s news article titled: “Ambev SA Sponsored ADR to Host Earnings Call” with publication date: October 26, 2017.Among 6 analysts covering AmBev SA (NYSE:ABEV), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. AmBev SA had 9 analyst reports since September 17, 2015 according to SRatingsIntel. Barclays Capital maintained Ambev SA (ADR) (NYSE:ABEV) on Friday, July 28 with “Hold” rating. Barclays Capital reinitiated the stock with “Equal Weight” rating in Thursday, November 3 report. As per Thursday, November 10, the company rating was upgraded by JP Morgan. The rating was maintained by Barclays Capital with “Equal-Weight” on Friday, October 27. Morgan Stanley downgraded it to “Equal-Weight” rating and $6.40 target in Thursday, August 18 report. The stock of Ambev SA (ADR) (NYSE:ABEV) earned “Outperform” rating by Credit Suisse on Tuesday, September 12. The stock of Ambev SA (ADR) (NYSE:ABEV) has “Buy” rating given on Monday, October 10 by Goldman Sachs.Denali Advisors Llc, which manages about $357.49M and $611.89M US Long portfolio, decreased its stake in Lear Corporation (NYSE:LEA) by 8,000 shares to 30,700 shares, valued at $4.36M in 2017Q2, according to the filing. It also reduced its holding in Robert Half International Inc. (NYSE:RHI) by 21,500 shares in the quarter, leaving it with 7,000 shares, and cut its stake in Avangrid Inc.. More recent Quest Diagnostics Inc (NYSE:DGX) news were published by: Nasdaq.com which released: “Quest Diagnostics (DGX) Beats Earnings in Q3, Updates View” on October 19, 2017. Also Finance.Yahoo.com published the news titled: “Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?” on October 16, 2017. Marketwatch.com‘s news article titled: “Quest Diagnostics: Proposed lab test cuts won’t hurt outlook” with publication date: October 19, 2017 was also an interesting one.Investors sentiment decreased to 0.99 in 2017 Q2. Its down 0.05, from 1.04 in 2017Q1. It turned negative, as 38 investors sold DGX shares while 200 reduced holdings. 78 funds opened positions while 158 raised stakes. 113.89 million shares or 2.51% less from 116.82 million shares in 2017Q1 were reported. Montgomery Management stated it has 12,535 shares or 0.64% of all its holdings. Moreover, Everett Harris & Ca has 0.01% invested in Quest Diagnostics Inc (NYSE:DGX). Baker Ellis Asset Limited Liability stated it has 2,250 shares. Highland Cap Mngmt Limited Liability Company stated it has 31,145 shares or 0.28% of all its holdings. Massmutual Tru Fsb Adv accumulated 162 shares or 0% of the stock. Ardevora Asset Mgmt Limited Liability Partnership, a United Kingdom-based fund reported 367,800 shares. Mackenzie Fincl Corp invested in 155,336 shares. Art Advsrs Ltd Company has invested 0.09% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). Endurance Wealth Management Inc accumulated 0.01% or 600 shares. Mirae Asset owns 2,535 shares. Glenmede Tru Company Na, Pennsylvania-based fund reported 147,288 shares. 45,053 are held by Gulf Bankshares (Uk). Piedmont Investment Advsrs Limited Liability Company has 38,375 shares for 0.09% of their portfolio. Moreover, Apg Asset Nv has 0.21% invested in Quest Diagnostics Inc (NYSE:DGX) for 1.05M shares. First Republic Invest Management Inc invested 0% in Quest Diagnostics Inc (NYSE:DGX).Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
